Repare Therapeutics Inc. (RPTX) [Rocket]

In millions, except per share items	Jun-30-23	Jun-05-23	Mar-31-23	Mar-05-23	Sep-30-22	Jun-30-22	Jun-05-22	Mar-31-22
	10-Q	8-K	10-Q	8-K	10-Q	10-Q	8-K	10-Q
Revenues					40.1	0.0		0.0
Cost of goods sold					39.4	0.0		0.0
Gross profit					0.7	0.0		0.0
Gross margin					1.7%	100.0%
Selling, general and administrative [+]					149.4	142.2		129.8
Sales and marketing					113.8	106.6		94.1
Other operating expenses					-92.9	-9.4		-8.1
EBIT [+]					-23.0	-132.2		-121.6
EBIT growth					-74.7%	69.6%		91.2%
EBIT margin					-60.8%	508.3%
Interest income					2.3	0.7		0.3
Interest income					2.8	0.8		0.3
Other income (expense), net					-3.8	-1.4		-0.5
Pre-tax income					-26.0	-133.1		-121.8
Income taxes					-0.3	-1.1		-1.5
Tax rate					1.1%
Net income					2.6	-103.7		-65.6
Net margin					6.5%	398.2%

Basic EPS [+]					$0.06	($2.61)		($1.71)
Growth					-106.8%			256.3%
Diluted EPS [+]					$0.06	($2.61)		($1.71)
Growth					-106.7%			256.3%

Shares outstanding (basic) [+]					40.9	39.7		38.5
Growth					24.7%	21.4%		56.1%
Shares outstanding (diluted) [+]					41.4	39.7		38.5
Growth					26.4%	21.4%		56.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.